CEFTARITZ INJ

CEFTARITZ INJ contains Ceftaroline Fosamil, a next-generation, broad-spectrum cephalosporin antibiotic used to treat complicated skin and soft tissue infections (cSSTI) and community-acquired bacterial pneumonia (CABP). It works by inhibiting bacterial cell wall synthesis, offering strong activity against multi-drug resistant organisms, including MRSA (Methicillin-Resistant Staphylococcus aureus).

Administered via intravenous injection, CEFTARITZ INJ is a trusted solution in hospital and ICU settings, especially when first-line antibiotics fail.

Key Features:

✅ Contains Ceftaroline Fosamil (dosage as per product strength)
✅ Active against Gram-positive and Gram-negative bacteria
✅ Effective in treating MRSA and drug-resistant Streptococcus pneumoniae
✅ Ideal for complicated bacterial infections
✅ For IV use only, under medical supervision